Discover the significance of PIRA in multiple sclerosis (MS) and how pharmacists enhance early detection and patient care in MS management.
Ryan Fuller, PharmD
Advertisement
Articles by Ryan Fuller, PharmD
Understanding the Multiple Sclerosis Disease Continuum and the Consequences of Untreated Progression
Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.
Advertisement
Latest Updated Articles
Pharmacist Best Practices in Early Multiple Sclerosis Detection and Disability IdentificationPublished: January 30th 2026 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Q&A: How Pharmacists Can Address Structural Barriers in Obesity Care
5